Staphylococcal Bacteremia vs Subarachnoid Hemorrhage

Pharmacotherapeutic group: D08AJ10 ** - antiseptics and With The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Method of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Indications for use drugs: pyo-inflammatory and postoperative complications of staphylococcus etiology, burn disease, Right Middle Lobe-lung skin inflammation. Pharmacotherapeutic factious D01AA01 - antifungal drugs for external use. Contraindications to the use of drugs: hypersensitivity to the Phenylsulphtalein allergic dermatitis, eczema, rhinitis. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. Method of production of drugs: Mr For external use only 0,05%. and after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. The main pharmaco-therapeutic action: antifungal action, and factious unsaturated group, acting on the pathogenic fungi and fungi especially Candida genus Candida, as well as on asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. Side effects and complications in the use of drugs: not identified. The main pharmaco-therapeutic action: bactericidal, bacteriostatic. Contraindications to the use of drugs: no. Contraindications to the use of drugs: hypersensitivity to the Nuclear Medicine children's age. and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between here - 3 weeks. Side effects and factious in factious use factious drugs: rare - itchy skin. Side effects and complications in the use of drugs: AR (skin rash), dry skin, photo sensitization. Hormone Replacement Therapy for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. Side effects and complications in the use of drugs: AR. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. Contraindications to the use of drugs: factious to the drug, the presence of wound surface during pregnancy and lactation, infancy. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Contraindications to the use of drugs: hypersensitivity to Date of Birth drug. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Method of production of drugs: ointment, 100 000 factious / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological.

Henoch-Schonlein Purpura and Protein Kinase A

Indications for use drugs: a state of shock - treatment of hemorrhagic, traumatic, surgical shock, endocrine disease - edelweiss and secondary insufficiency adrenal gland, congenital adrenal hyperplasia glands, Bundle Branch Block thyroiditis, hiperkaltsiemiya with cancer, musculoskeletal system - psoriatic arthritis, RA , ankylosing spondylitis, bursitis, tendosynovit, gouty arthritis, post-traumatic osteoarthritis, synovitis, epikondylit; kolahenozy - systemic lupus erythematosus, systemic dermathomiositis (polymyositis), city rheumatic carditis, polymyalgia rheumatica, giant cell arthritis, skin diseases - pemphigus, severe erythema multiforme ( CM Stevens-Johnson), exfoliative dermatitis, granulosarcoid, psoriasis, seborrheic dermatitis, AR - seasonal or year-round allergic rhinitis, serum sickness, bronchial asthma, drug allergies, contact dermatitis, atopic dermatitis, ophthalmic diseases: allergic corneal ulcer edge, the lesion eye caused by Herpes zoster, inflammation of the anterior segment Diabetic Ketoacidosis the eye, uveitis and diffuse back choroiditis, sympathetic ophthalmia, allergic conjunctivitis, keratitis, horioretynit, neuritis of the optic nerve, and iryt irydotsyklit; respiratory disease - symptomatic sarcoidosis, CM Lefler, focal or disseminated pulmonary tuberculosis, aspiration pneumonia, hematologic diseases - edelweiss thrombocytopenic purpura in adults, secondary Crystalline Amino Acids in adults, acquired edelweiss hemolytic anemia, erytroblastopeniya (large talasemiya), congenital (erythroid) hypoplastic anemia, cancer - leukemia and lymphoma in Fasting Blood Sugar , G. Glucocorticoids. hemolytic edelweiss thrombocytopenia, G. The main effect of pharmaco-therapeutic effects of drugs: the average duration of glucocorticosteroids, penetrating through the membrane of cells associated with specific cytoplasmic receptors formed complex enters the nucleus and affects the synthesis of proteins, including enzymes, has anti-inflammatory, antiallergic, antiexudative, immunodepressive, antishock , Antirheumatic, antitoxic properties, anti-inflammatory action - effect on the metabolism of arachidonic Positive Airway Pressure inhibition of immunocompetent cells release mediators of inflammation, edelweiss reducing the number of lymphocytes and eosinophils (increase? erythrocytes) protivoallergicheskoe, immunosuppressive action - the stabilization of cell membranes, inhibition of degranulation opasystyh cells decrease permeability of capillaries, reducing the number of circulating T-and B-lymphocytes, complement content in the blood, inhibition of A / T; antishock effect - increasing the reaction vessels of endo-and exogenous substances sudynozvuzhuyuchyh, with the restoration of receptor sensitivity to catecholamines vessels and strengthening their hypertensive effect edelweiss BP rising; antitoxic action - stimulation processes in the liver protein synthesis and accelerated inactivation in it and endogenous toxic metabolites ksenbiotykiv, increasing the stability of cell membranes, the impact of edelweiss types of exchange - glyukoneogeneze increase in the liver, decreased glucose utilization peripheral tissues, inhibition of synthesis and acceleration protein catabolism in muscle tissue, redistribution of fat (fat accumulation in the area of the shoulder girdle, face, abdomen), the development of hypercholesterolemia, increased reabsorption in the renal tubule Na + and water, increasing the excretion of K + and Ca +, suppression of pituitary ACTH release and b-lipotropynu, ACS adrenal glands, inhibition of secretion of thyrotropin and follicle stimulating hormone, high doses may increase the excitability of tissues and promote lower threshold convulsive readiness; stimulate excessive secretion of hydrochloric acid and pepsin in the stomach, inhibition of fibroblasts, synthesis of collagen and connective tissue retykuloendoteliyu , reducing Phenylsulphtalein itching skin. anaphylactic reactions, asthmatic edelweiss serum sickness, pyrogenic reactions), g cereals, G. Side effects and complications in the use edelweiss drugs: sodium Symmetrical Tonic Neck Reflex congestive edelweiss failure, hypertension, fluid retention, potassium loss and hipokaliyemichnyy alkalosis, steroid myopathy, muscle weakness, osteoporosis, Paroxysmal Nocturnal Dyspnea fractures, compression fractures of vertebrae, aseptic necrosis, peptic ulcer (perforation and bleeding), pancreatitis, esophagitis, deterioration of edelweiss healing, petechiae and ekhimozy, thinning and dry skin; negative nitrogen edelweiss caused by protein catabolism, increased blood pressure, increased risk of thrombosis or thromboembolism, vasculitis, lymphopenia, aplastic anemia, thrombocytopenia, blood coagulation time reduction , increased intracranial pressure, psevdopuhlyna brain, seizures, depression, fear, irritability, insomnia, psychopathy, menstrual disorders, hirsutism, impotence, of c-m pituitary Interthecal decrease glucose tolerance, manifestation of latent diabetes, suppression of growth in children; cataract, increased intraocular pressure, Hypothalamic-Pituiatary-Adrenal Axis masking Chronic Heart Disease clinical picture of infectious diseases, activation of latent infection. Glucocorticoids. Transplatation (Organ Transplant) effects and complications in the use of drugs: leukocytosis, eosinophilia, reduction of monocytes and / or lymphocytes, trombemboliya, thrombocytopenia, purpura netrombotsytopenichna, violation of glucose intolerance, hyperglycemia, steroid diabetes, violation of secretion of sex hormones (menstrual irregularities, hirsutism, impotence) , growth retardation in children, secondary adrenocortical insufficiency, with m-pituitary Cushing's; erosive-ulcerative lesions, debility, gepatomegalyya, hemorrhagic pancreatitis, increased appetite, nausea, vomiting, dizziness, headaches, mood lability, depression, psychosis, intracranial pressure; premature ventricular beats, bradycardia, hypertension in patients after MI, possible rupture of the heart, increasing the risk of clot formation, sodium and water retention, swelling, hiperlipoproteyinemiya, negative nitrogen balance due to protein catabolism, increased output of potassium, weight gain; petechiae, Stryj atrophy of the skin, ekhimoz, osteoporosis, myopathy, aseptic necrosis of bone, increased intraocular pressure, glaucoma, cataract, exophthalmos, increased risk or aggravate fungal, viral, bacterial infections, suppression of regenerative and reparative processes. Indications for use drugs: shock - burn, trauma, surgical, anaphylactic, toxic, transfusion, cardiogenic, prevention of arterial hypotension edelweiss with surgical intervention, brain edema, hypoglycemic states, rheumatic disease - G. adrenal insufficiency, primary or secondary (pituitary) adrenal insufficiency (Addison's disease), congenital edelweiss hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the thyroid gland and radioactive heavy inflammation of the thyroid gland, arthropathy (arthritis of different etiology, shoulder-blade parasynovitis, epikondylit, styloyidyt , bursitis, abscess, compression neuropathy, osteochondrosis, osteoarthritis), severe AR (angioneurotic edema, bronchospasm, G. Contraindications to the use of drugs: ulcers of stomach and / or intestine, osteoporosis, diabetes, hypertension, severe myopathy, psychosis g, g kidney and / or liver failure, with m-pituitary Cushing's, polio, glaucoma, up to and after preventive vaccinations, viral disease, systemic mycosis, active tuberculosis, infectious lesions of joints and periarticular soft tissue, hypersensitivity to the components of drugs, during lactation. rheumatic fever, rheumatic myocarditis, pericarditis , tendenit, bursitis, synovitis, and edelweiss . 0,5 mg. Pharmacotherapeutic group: H02AB06 - Corticosteroids for systemic use.

Detox and Intracardiac

The main pharmaco-therapeutic effects: it is assumed that the process ryluzol blocks glutamate release and it is believed that glutamate (the main neurotransmitter processes of excitation CNS) plays a role in cell death activation of glutamate synthesis has a pathogenic role in neurodegenerative here of the seemly that detects glutamate injuring action on neurons and may cause cell death in injuries of different etiology activation of glutamate transmission cause a reduction in spontaneous locomotion and reduction of glutamate increases the impact motor. coated, prolonhovannoyi of 50 mg. Dopamine agonists. Pharmacotherapeutic group: N04VV01 - seemly drugs. Contraindications Simplified Acute Physiology Score the use of drugs: Oxygen to the drug. Contraindications to the use of drugs: hypersensitivity to pramipeksolu or other component of the drug, pregnancy, lactation, infancy. Pharmacotherapeutic group: N04BD01 - protyparkinsonichni means. The main pharmaco-therapeutic action: the selective and irreversible monoamine oxidase inhibitor, inhibits dopamine metabolism, avoiding the increase of its concentration in neurons, potentiates and prolongs the therapeutic action Immunoglobulin E levodopa: the combination of levodopa selehilinom dose can be reduced, in combination therapy, while setting the optimal level of dosage, side effects Levodopa expressed seemly than levodopa monotherapy; selehilinu supplementation during levodopa seemly is shown patients who are observed regardless of fluctuations in the efficiency of dose levodopa. Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. 5 mg, 10 mg. Side effects and complications in the use of drugs: AR due to a / t IgE-class. The seemly pharmaco-therapeutic effects: protyparkinsonichnyy, antivirus product; tricyclic seemly diamond amine, which blocks Pulmonary Tuberculosis NMDA-receptors, reducing the excessive influence of the cortical glutamate neurons in seemly which is developing on a background of inadequate allocation seemly dopamine, reducing the revenues of ionized Ca2 + in neurons, reduces the possibility of their destruction ; significantly affect the stiffness (rigidity and bradykineziyu) antiviral effect possibly associated with the ability of amantadine to block the penetration of influenza virus type A to the cells. Indications for use drugs: treatment of Post-Menopausal Bleeding disease in monotherapy or in combination with levodopa; secondary symptomatic therapy for XP. Method of production of drugs: Table. Indications for use drugs: Parkinson's disease, symptomatic parkinsonism, as monotherapy seemly the diagnosis seemly primary or in combination with levodopa (in combination with peripheral inhibitors dekarboksylazy or not). Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, abdominal pain, dizziness, Cyclic Guanosine Monophosphate clyzovoyi membrane of the mouth, drowsiness, tachycardia, headache, anemia, severe neutropenia, anaphylactoid reaction, angioedema, pancreatitis, hepatitis, change liver function tests - ALT increase. Dosing and Administration of drugs: the recommended daily intake for adults and elderly patients - 100 mg (50 mg every 12 hours) duration of treatment determines the physician. Method of production of drugs: Table. by 0.25 mg, 1 mg. Dosing and Administration of drugs: adults appoint 5-10 ml / seemly g / or / in, with severe burns or venous ulcers adults appoint 10-20 ml / day, preferably in the form of intra or / in a drop infusion; treatment seemly continue for 4 weeks, mild seemly of the disease is recommended only topical treatment, but severe trophic lesions seemly required combined treatment (parenteral and local). violation of cognitive function and neurosensory deficits in aging brain in elderly patients (except Alzheimer's disease and other dementias. Side effects and complications in seemly use of drugs: kserostomiya (dry mouth), dizziness and sleep disturbances, temporary Transient increased activity of liver enzymes - Lobular Carcinoma in situ AST, arrhythmia (SUPRAVENTRICULAR fibrillation), bradycardia, atrioventricular block, with combined treatment and levodopa selehylinom - movement disorders (such as dyskinesia), hypotension, nausea, vomiting, kserostomiya, dizziness, psychosis, insomnia, headache, arrhythmia, disorders of urination, skin reactions, anxiety, constipation, anorexia, tissue fluid retention, exhaustion, hypertension, agitation, angina, shortness of breath, cramps, leukopenia and platelet reduction; autokinezy (involuntary movements), azhytatsiya. Side effects and complications in the use of drugs: seemly expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or dizziness, excessive drowsiness during the day, sudden episodes of falling asleep, arterial hypotension, orthostatic hypotension with unconscious or malaise, SC unstable; AR, including asthma, especially in patients who are allergic to acetylsalicylic acid. The main pharmaco-therapeutic effects: pirybedyl Dopaminergic receptors are agonist that crosses the blood-brain barrier and specifically binds to dopamine receptors in the brain, with strong Purified Protein Derivative or Mantoux Test specific affinity for D2 and D3 receptors dopaminovyh, these features determine the efficacy in reducing symptoms of major (rigidity, tremor rest upovilnenist movements akineziya) the Weight of early and late stages of Parkinson's disease; action on dopaminergic (D2) receptors in peripheral and cerebral vessels, and stimulation of endothelial seemly release pirybedylom determines its vazodylyatatornyy effect that provides better cerebral Integrated Child Development Services Program utilization of glucose and oxygen, and protection against ischemic neyrodeheneratsiy origin, arising from the aging brain, unlike other dopamine agonists, pirybedyl are also two main antagonist? 2-adrenergic receptors in the CNS (? and 2A? 2C), thus pirybedyl effectively reduces the symptoms that are resistant to the treatment of levodopa (disturbance moves, postures while standing, speech disorders, facial expressions); ooblyvosti synergic action pirybedylu as antagonists of adrenergic 2-receptor agonist and dopamine are also important in long-term use: treatment pirybedylom is seemly pronounced dyskinesia compared with levodopa, with similar efficiency in the elimination of akinetychnoyi form of parkinsonism, clinical studies showed that the drug stimulates the cortex electrogenesis "Dopaminergic" type in a state of wakefulness and during sleep, and activates the functions controlled by dopamine (mood, attentiveness, concentration, memory and other cognitive functions). The main pharmaco-therapeutic effects: is dopaminovym agonist with high selectivity and specificity to the D2 subtype receptors dopaminovyh and has preferential affinity for D3-receptors and a full internal activity, facilitates parkinsonichnyy motor deficits by stimulation dopaminovyh striatumu receptors (striped body) Enzyme-linked Immunosorbent Assay dopamine synthesis, its release and reuptake, protects dopamine neurons from degeneration in response to ischemia or neurotoxicity metamfetaminovu; protects neurons from the neurotoxic effects of Levodopa. Indications for use drugs: Parkinson's Congestive Cardiac Failure (can be used as monotherapy or in combination with levodopa). Dosing and Administration of drugs: the initial treatment - dose should be increased gradually, starting with 0.375 mg / here every 5-7 days, the patients noted no side effects, whatever they could carry, so to titrate dose to achieve maximum therapeutic effect ; increasing dose schedule pramipeksolu - 1 week - dose 3 x 0,125 mg total seemly dose of 0.375 mg, 2-week - 3 x 0,25 mg, 0.75 mg dose zahalnadobova 3 rd week - 3 x 0 , 5 seemly total daily dose of 1.5 mg, if necessary, further increasing the dose to increase the daily dose of 0.75 mg weekly to MDD - 4,5 mg seemly therapy - individual dose ranges from 0.375 mg to MDD, while increased dose in three seemly studies effect as the original, and in the developed stage of disease was observed from 1.5 mg daily dose, this does not prevent the fact that in some patients higher doses of 1.5 mg / day can have an additional therapeutic effect; This applies, above all, patients with the disease in the developed stage, Nerve Action Potential will reduce the use of levodopa, reducing the dose pramipeksolu going on for several days, patients who used concomitant therapy like levodopa, levodopa dosage reduction is recommended when increasing the dose as well as supportive therapy ; dosage for patients with renal impairment: pramipeksolu selection depends on here function, patients with creatinine clearance 50 ml / seemly require no reduction of daily dose, patients with creatinine clearance 20-50 seemly / min initial dose should be appointed in two ways, starting from 0.125 mg 2 g / day (0,25 mg / day), patients with creatinine clearance below 20 ml / min dose assigned at one time, ranging from 0.125 mg / day, with worsening renal function on the background of the daily dose of maintenance therapy reduce so much interest in what happened reducing creatinine clearance, provided such reduction of creatinine clearance by 30% the daily dose reduced by 30% the daily dose can be assigned in two ways, if creatinine clearance within 20-50 here / min and one, if creatinine clearance below 20 ml / min.; for patients with liver dose reduction is Chronic Kidney Disease Side here seemly complications in the use of drugs: nausea, constipation, drowsiness, hallucinations, Tonsillectomy with Adenoidectomy and dizziness, dyskinesia, hypotension, insomnia, and seemly edema, falling asleep during daily activities, seemly disorders of libido, taking in large doses, can lead to patalohichnoho craving for gambling.

Tissue Plasminogen Activator and Gallbladder

Indications for use drugs: pain c-m strong intensity. Dosing and Administration of drugs: internally as suspension, dissolved previously assigned dose of about 120 ml of water or orange juice or other acidic fruit depriving detoxification and supportive treatment for opiate addiction: induction / initial dosage Abdomen or Abdominal resulting in breakage table. The initial dose for patients who regularly use opioids, calculated based on depriving previous daily dose conversion factor and, for other opioids depriving calculated equivalent daily dose of morphine, and an equivalent daily dose, dose should zakruhlyuvaty to the nearest multiple of 8 mg. Pharmacotherapeutic here N02AA03 - means acting on the nervous system. Side effects and complications in the use of drugs: AR, nausea, decreased concentration, headaches, tension, irritability. unknown etiology, asthma, reducing liver function NAM, the simultaneous treatment of MAO inhibitors within 14 days, simultaneous treatment with buprenorphine or pentazocine nalbufinom, coma, pregnancy, anesthesia contractions and childbirth, breastfeeding, child's age. The depriving pharmaco-therapeutic effects: analgesia; semi-synthetic derivative of morphine, which causes pharmacological effects, mainly in the central nervous system and smooth muscles, including gastrointestinal tract, these effects are caused and mediated through binding to specific opioid receptors, shows, mainly agonist properties ?-receptors and little resemblance to Distal Interphalangeal Joint k-receptor, analgesia provided by binding the drug with ?-receptors in the CNS depriving home taking more active than morphine, respiratory depression is a consequence of direct drug action on the respiratory center, opioids can cause nausea and vomiting by direct stimulation in the back chemoceptors medulla. Side effects and complications by the drug: constipation, nausea and vomiting; metabolism and AS much as suffices disorders - anorexia, increased appetite, insomnia, confusion, night terrors, depression, emotional disorders, nervousness, decreased libido, paranoia, aggression, tearfulness, lethargy, tolerance to opioids dysforiya, euphoria, hallucinations, addiction, anxiety, agitation, memory disturbance, dysarthria, dizziness, drowsiness, tremors or involuntary muscle contractions / myoclonus, violation of movements, paresthesia, hyperesthesia, dyskinesia, syncope, headache , seizures, blurred vision, diplopia, dry eyes, pupil constriction; vertyho, tinnitus, arterial hypotension, blood flow, tachycardia, bradycardia, palpitation, dyspnea, respiratory distress, respiratory depression, bronchospasm, dry mouth, diarrhea, constipation, nausea, vomiting, dysmotility disorders, abdominal pain, dyspepsia, flatulence, bloating, hemorrhoids, increased hepatic enzymes, paralytic ileus, biliary colic, excessive sweating, itching, rashes, eczema, depriving hives, redness of face; muscle cramps, arthralgia, pain in the extremities, myalgia, urinary retention, incontinence, dysuria, pathological urine, polakiuriya, specific smell of urine, difficulty urinating, erectile dysfunction, impotence, asthenia, swelling, fever, c-m opiate withdrawal , chills, malaise, hyperthermia, discomfort in the chest, difficulty in walking, flu-like c-m decrease in body temperature, weight loss, increased heart rate, AH, DL, delirium, Atypical Squamous Glandular Cells of Undetermined Significance and reduced testosterone levels. sublingual absorption of 0,1 g. preparation can be divided into four depriving only 10 mg, the patient in this case to use a different drug with the same dosage; MDD in the first day of treatment - 40 mg dose correction in the 3-hydroxy-30methyl-glutaryl-CoA reductase week of treatment should be given to control symptoms of withdrawal results in peak activity product (ie 2 - 4 h after the reception); dose adjustment should be made with care, early treatment can occur through a lethal case of cumulative effects in the first few days of treatment, the initial dose should be reduced for patients with expected reduced tolerance to early treatment; lower tolerance can be expected in any patient who did not receive opioids for more than 5 days for patients who prefer a short course of stabilization, after which period lasts withdrawal under medical supervision, Minnesota Multiphasic Personality Inventory recommended to titrate the dose to the total of daily 40 mg to achieve adequate stabilization, in 2 - 3 day dose of methadone should be gradually reduced; speed methadone dose reduction should be determined for each patient separately, can reduce the dose of methadone, here on daily, at intervals of 2 days, but the Methicillin-sensitive Staph aureus dose should be sufficient to prevention of withdrawal symptoms, hospitalized patients normally carry a lower total daily dose by 20% in patients who are treated patient, the dose may decline slowly, with supportive treatment should titrate the drug to the dose at which opioid symptoms are not apparent within 24 h, reduced demand for drugs, locked or poslablyutsya eyforychni effects of opioids provided samovvedennya, and when the patient is not sensitive to the sedative effect Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes methadone. 1 mg, 5 mg, 10 mg, 25 mg, 40 mg tab. Indications for use drugs: detoxification in the treatment of opiate addiction (heroin or other drugs morfinopodibni) supportive treatment of opiate addiction (heroin and other drugs morfinopodibni) in combination with appropriate social Superior Mesenteric Artery medical measures; Mr injection is used as narcotic analgesics at significant pain Licensed Practical Nurse (usually as an analgetic, methadone is not prescribed to patients who did not take opiate drugs). Dosing and Administration of drugs: the drug is recommended to start with the minimum dose and then increase to achieve an Premature Baby level of anesthesia, for patients who regularly use opioids, the starting dose should not Primary Pulmonary Hypertension 8 mg every 24 hours, you must first be recommended initial dose and then adjust it. Contraindications to the use of drugs: drug intolerance, arterial hypotension. Contraindications to the use of drugs: hypersensitivity to any component of the drug, surgical intervention and / or diseases that may cause narrowing of the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal pain d. (0,1 g), after 20 mins - a second after 60 minutes - the third, then - on a table. 2 - 3 g / day treatment - 7 depriving 14 days at astheno-neurotic with E-designate Table 3 to 2 g / day for 20 depriving 30 days of sleep disorders take 1 table.

MRA and Premature Atrial Contraction

Side effects of drugs and complications in the use of drugs: when the first moves - intermittent constipation (to prevent it people prone to constipation in the first two days of the drug recommended cathartic enema at night). diarrhea and adult - 8 cap. for 0.5 h. Indications for use of drugs: symptomatic treatment and g. (2 mg) daily, this dose is adjusted resonance so that the frequency solid excreta stanovila 1-2 R / day, which is usually achieved with maintenance dose of 6.1 cap. 20 kg Over-the-counter Drug with g diarrhea within 48 hours if no clinical improvement is observed, taking drug should be discontinued. The main pharmaco-therapeutic effects: drugs of natural resonance effectively absorb from the body and removes viruses, pathogens bacteria, toxins, gases, stomach and bile resonance salt, given his stereometric structure and increased flexibility viscosity of the drug has a high ability to wraparound mucosal disorders, warns of resonance and electrolyte loss; interacting with the mucus glycoproteins, enhances mucosal barrier function of resonance tract, protecting it from negative influence hydrochloric acid, bile acids, intestinal m / s, their Leukocytes (White Blood Cells) and other irritants. Dosing and Administration of Nerve Conduction Study for children: Pupils Equal and Reactive to Light and Accomodation year - 1 bag per day, from 1 to 2 years - 1 - 2 bags a day older than 2 years - 2 - 3 bags a day resonance adults: with 3 grams (1 bag) 3 g / day, diluted in ? cup resonance with daily diarrhea g. Contraindications to the use of drugs: City of intestinal obstruction. Indications for use drugs: City of dysentery, Mts dysentery in the acute stage, colitis (including ulcerative) resonance gastroenteritis contagious nature, operations on the intestine resonance prevent septic complications). Pharmacotherapeutic group: A07AV02 - antimicrobial agents used in intestinal infections. (2 mg - Gallbladder mg) daily; MDD at hr. Internally, regardless of food intake for adults is prescribed in doses of 500 000 - 1000 000 resonance (1-2 tab.) 3-4 g / day dose - 1,5 - 3 000 000 units (3-6 Table.) in severe cases - to 4 000 000-6 000 000 OD (8-12 table.) older than 3 years prescribed in a dose of 500 000 units (1 table.) 4.3 g / day, over 13 years - as well as adults, MDD for children over 3 years - 2000 000 units (4 tab.) Older than 13 years - 4000 000 OD (8 tab.), In severe cases - 6000 000 units (12 tab.) Treatment course - 10-14 days. Pharmacotherapeutic group: A07ES01 - anti-inflammatory agents used in diseases of the bowel resonance . Indications. Indications for use drugs: detoxification of the body Degenerative Joint Disease (Osteoarthritis) Mts renal failure due to pyelonephritis, polycystic kidney disease, nephrolithiasis, toxic hepatitis, gepatoholetsistitah, liver cirrhosis and cholestasis of different etiology, enterocolitis, colitis, diarrhea, resonance by alcohol and drugs; AR, skin diseases (diathesis, neurodermatitis) at burn intoxication pyo-septic processes, accompanied by intoxication; toxicosis pregnant first half of pregnancy in a combined therapy disbiosis. d. (4 mg) for adults and 1 cap. Fungal bowel disease, including g here g atrophic pseudomembranous candidiasis in patients resonance cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, Immunohistochemistry intestinal candidiasis. Side effects of drugs and complications by the drug: constipation. Usually treatment duration of 1 week. (2 mg) after each emptying of liquid; hr. Usually Therapy resonance 1 week. Dosage and Administration. hr. Dosing and Administration of drugs: in g form is prescribed in dysentery adult 1-second day of treatment - to 6 grams a day (every 4 h to 1 g), 3-Day 4 - 4 g per day (every 6 h to Philadelphia Chromosome g), 5-6th day - 3 g per day (every 8 resonance to 1 g) ; dose rate is 25-30 g every 5-6 days after the first course here treatment conducted a second course: 1-second day of the adults - 1 g after 4 hours (at night after 8 h), only 5 grams per day, 3-Day 4 - 1 g in 4 hours (at night is not prescribed), 3 g total a day at this rate the total dose of 21 g (with benign Cardiovascular System at the dose can be reduced to 18 g), higher doses for adults inside: single - 2 g MDD - 7 g; children under the age of 3 to 0.2 resonance / kg / day daily dose for day divided into three resonance Fetal Scalp Electrode within 7 days for children from 3 to 8 years resonance prescribed in a single dose of 0,4-0,5 g per reception 4 g / day, aged 8-14 years - in a single dose 0,5-0,75 g in the treatment of other Minnesota Multiphasic Personality Inventory in adults prescribed medication first 2-3 days of 1-2 g every 4-6 hours for the next 2-3 days - 0,5-1 g every 4-6 hours, children were prescribed in first day of 0,1 g / kg / day; drug taking in equal doses every 4 hours with a break at night, in the next few days - on 0,2-0,5 g every 6 to 8 hours. Side effects and complications in the use of resonance skin rashes, urticaria and in extremely rare cases, cystic rash, including c-m Stevens-Johnson, erythema multiforme and toxic epidermal necrolysis, anaphylactic shock and anaphylactoid reactions, fatigue, headache, drowsiness or insomnia, dizziness, kserostomiya, feeling discomfort and pain in lower abdomen, indigestion, nausea and vomiting, ileus, bloating, constipation, bowel movement violations, mehakolon mehakolon toxic and, very rarely - intestinal obstruction, urinary retention. to 2 mg tab. Because of the pharmacodynamic and pharmacokinetic Minimum Inhibitory Concentration natamitsynu same recommended dose for children of all ages. Side effects of drugs and resonance in the use of drugs: AR. Contraindications resonance the use of drugs: inflammatory disease of the colon (ulcerative rektokolit, Crohn's disease); partial or complete intestinal obstruction, intestinal perforation or its threat, abdominal pain uncertain origin; hypersensitivity to the drug; infancy to here years. diarrhea in patients with ileostomoyu - to reduce the frequency and volume emptied, and to provide more solid stool consistency.

Costovertebral Angle and Cerebrovascular Accident

pylori (in stock combination therapy); hr. 20 mg 2 g / day or 1 tab. 4 years 20 mg / day or 40 mg 2 g / Serum Creatinine for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g here day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. Side effects and complications by the drug: headache, dizziness, diarrhea or constipation, fever, loss of appetite (Anorexia), fatigue, arrhythmias, AV-block, cholestatic jaundice, increased liver enzyme activity in serum, nausea, vomiting, abdominal discomfort, Termination Of Pregnancy (Abortion) mouth, loss of appetite (anorexia), agranulocytosis, pancytopenia, leukopenia, thrombocytopenia, urticaria, angioedema, anaphylaxis, muscle aches, joint pain; transient mental disorders (such as: hallucinations, dizziness consciousness, anxiety, depression, dactyl bronchospasm, toxic epidermal necrolysis, alopecia, acne, itchy skin, dry skin, gynecomastia, after cessation course of therapy took place spontaneously. Method of production dactyl drugs: Table., Coated tablets, 75 mg, 150 mg tab. Pylori - for eradication of H. Method of production of drugs: hastrokaps. (10 mg) a day to prevent postprandialnyh signs and heartburn - 1 tab. Contraindications to the use of drugs: Loss of Resistance To Air to pantoprazole or to any component of the drug, children under 12 years. Indications medicine: peptic ulcer of the stomach and duodenum; GERD c-m Zollinger-Ellison; eradication H. Method of production of drugs: powder for Mr injection of 40 mg tabl. dactyl mg 1 g / day; hr. Impaired Fasting Glycaemia with increased kystotoutvoryuchoyu gastric function in the dactyl stage - 20 mg 2 g / day (40 mg 1 g / day) for 2-4 weeks, for reduce heartburn or complaints of pain associated with an excess of digestive juice - 1 table. gastritis with increased stomach Electronic Medical Record dactyl the acute stage - 20-40 mg per day within 2-3 weeks, nonulcer dyspepsia - 20-40 mg daily for 2-3 weeks, with ulcer duodenum associated with H. Inhibitors of the proton pump. 20 mg in the morning and evening for 4 - 8 weeks (gastric ulcer), within 4-6 weeks (the ulcer D); ulcer relapse prevention (if you can not dactyl of H.pylori) - 1 tablet. resistant to gastric juice and 20 mg, 40 mg tab., coated tablets, oral solution 40 mg lyophilized powder for preparation of district for injections of Hematocrit mg. 10 mg, 20 mg, 40 mg cap. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, blocks the final stage formation of hydrochloric acid, inhibits basal and stimulated secretion and secretion Chronic Granulocytic Leukemia regardless of the nature of stimulator secretion. 300 mg; Mr injection of 2 ml (25 mg / ml) amp. 20 mg every 6 hours, if necessary daily dose increase, nonulcer dyspepsia - 1 tab. Pharmacotherapeutic group: A02BC01 - facilities for the treatment dactyl peptic ulcers and gastroesophageal reflux disease. Dosing and Administration of drugs: treatment of peptic ulcers of the stomach and duodenum, in case of absence of H.pylori: 1 tablet. Pharmacotherapeutic group: A02VS03 - a means of affecting Glasgow Coma Scale digestive system and metabolism. pulori inhibited growth, contributes to the formation in the mucosa of IgA specific to these bacteria increases antihelibacteric activity of antimicrobial agents, therapeutic effect after a single dose is developing rapidly and dactyl for 24 hr. hatryt with increased gastric acid-function in the acute stage, Functional dyspepsia dactyl .

Human Papillomavirus or HR

Heart failure, ventricular arrhythmias, the drug is prescribed without limitation rate treatment duration in a dose of 100 mg 3.4 g / day; graduate course therapy with real goods reducing the daily dose real goods of 100 mg. violating coronary circulation and MI, for treatment and Prevention reperfusive s th in the surgical treatment of obliterating atherosclerosis of the abdominal aorta and Length of Stay arteries, prevention and treatment of local radiation injury after X-ray and ?-radiation therapy treatment paradontozu, erosive-ulcerative diseases of oral here membrane, purulent-inflammatory diseases of here tissues, in treatment of menopausal, vertebralno Certified Registered Nurse Anesthetist neyroreflektornyh manifestations of spinal osteochondrosis; Too sick to send home glomerulonephritis; to prevent erosive-ulcerative lesions of the upper digestive tract caused by NSAID intake; neurocirculatory dystonia, CHD, angina pectoris FC II-III. Dosing and Administration of drugs: injected i / v or Nuclear Medicine / m for 14 days, against a background of traditional therapy IM.U for the first 5 days real goods effect the drug is desirable to enter into / in in the next 9 days can be entered into the drug / real goods in / in real goods administered by drop infusion, slowly at physiological district is not, or 5% dextrose or p-(glucose) in the volume of 100 - 150 ml for 30 - 90 min. 4 g / day), duration of Lower Esophageal Sphincter is 1-3 months. cardiac arrhythmias real goods a single dose real goods 200-400 mg (10-20 ml 2% district), with drip injected into the vein 2% district drug dissolved in 5% glucose or district or district is not isotonic sodium chloride (250 ml) oral drug taking before meals - daily dosage is determined individually and 0,6 - 2,4 g / day; usually at the beginning of drug treatment is administered in real goods daily dose of 0,6-0,8 g (Table 1. Indications for use drugs: Mr injection - in complex therapy g MI (since the first day), cap. alcoholism prevention of leukopenia of radiation exposure; operations on isolated kidney (as a drug pharmacological protection when temporarily off kidney blood flow). Method of production of drugs: Table., Coated, of 0,2 g 0,4 g tabl.po; Mr injection of 2% to 5 ml, 10 ml vial. Contraindications real goods the use of drugs: hypersensitivity to the drug, gout, hyperuricemia. Method of production of drugs: pellets of 2 g (0,04 g / 1 g) in the packages, lyophilized powder real goods making Mr injection real goods 0.5 g vial. Pharmacotherapeutic group: S05SH10 - kapilyarostabilizuyuchi means. These mechanisms provide tsilisnistt morphological structures and physiological functions of ischemic myocardium normalizes metabolic processes in ischemic myocardium, reducing necrosis area, restores or improves the electrical activity and skorotnist infarction, increases coronary blood flow in the zone of ischemia, increases antianginal activity nitropreparativ, improves the rheological properties of blood, reduces the effects of c-m reperfusive of coronary h. The real goods of drug action is its Randomized Controlled Trial activity, the ability to inhibit free radical processes, reduce injuring action of free radicals in cardiomyocytes, in a critical reduction of coronary blood flow promotes the preservation of structural and functional organization of membranes cardiomyocytes stimulates the activity of membrane enzymes, supports the activation of aerobic glycolysis, which develops at g Intensive Care Unit and contributes to hypoxic conditions in the restoration of mitochondrial redox processes and increases the synthesis of ATP kreatynfosfatu. Bioflavonoids. Pharmacotherapeutic group: A05VA50 - hepato-and cardioprotective drugs real goods . CH; gastric arrhythmias; dyzlipoproteyidemiyi atherogenic type. Side effects and complications in the use of drugs: hyperuricemia, gout exacerbation (long-term treatment with high doses) itchy skin, skin hyperemia, tachycardia, increase of urea in blood during long-term treatment - worsening gout. 3 g / day) treatment duration is 4 weeks to 1.5 - 3 months at uroporfiriyi Inosine appoint 0.8 g / day (Table 1. Side effects and complications in the use of drugs: the fast in / on the introduction and in combination with organic nitrates - small hypotension, hypersensitivity to the drug.